Y030-2081 Screening compound: N-(diphenylmethyl)-3,5-dimethoxybenzamide

Y030-2081 Screening compound: N-(diphenylmethyl)-3,5-dimethoxybenzamide
Y030-2081 Screening compound: N-(diphenylmethyl)-3,5-dimethoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y030-2081
N-(diphenylmethyl)-3,5-dimethoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y030-2081

Molecular Formula

C22H21NO3 (C22 H21 NO3)

Compound Name

N-(diphenylmethyl)-3,5-dimethoxybenzamide

IUPAC name

N-(diphenylmethyl)-35-dimethoxybenzamide

SMILES

COc1cc(C(NC(c2ccccc2)c2ccccc2)=O)cc(OC)c1

InChI

InChI=1S/C22H21NO3/c1-25-19-13-18(14-20(15-19)26-2)22(24)23-21(16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-15,21H,1-2H3,(H,23,24)

InChI Key

FOGQPQUPSOUSKC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01215860

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

347.41

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.463

Distribution Coefficient, logD

4.462

Water Solubility, LogSw

-4.42

Polar Surface Area

38.820

Acid Dissociation Constant (pKa)

10.78

Base Dissociation Constant (pKb)

-5.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.60

Y030-2081 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

DGK Inhibitors Library (10558 compounds)

Dark Chemical Matter Library (18430 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Pool
Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with Y030-2081 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y030-2081?
Check Price and Availability of Y030-2081, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y030-2081 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y030-2081
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y030-2081
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y030-2081 available by request